MDXH Valuation
MDxHealth SA
$
4.680
- Overview
- Forecast
- Valuation
- Earnings
MDXH Relative Valuation
MDXH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MDXH is overvalued; if below, it's undervalued.
Historical Valuation
MDxHealth SA (MDXH) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -3.68. The fair price of MDxHealth SA (MDXH) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：4.68
Fair
-12.08
PE
1Y
3Y
5Y
Trailing
Forward
45.52
EV/EBITDA
MDxHealth SA. (MDXH) has a current EV/EBITDA of 45.52. The 5-year average EV/EBITDA is -19.69. The thresholds are as follows: Strongly Undervalued below -131.98, Undervalued between -131.98 and -75.84, Fairly Valued between 36.45 and -75.84, Overvalued between 36.45 and 92.60, and Strongly Overvalued above 92.60. The current Forward EV/EBITDA of 45.52 falls within the Overvalued range.
-47.76
EV/EBIT
MDxHealth SA. (MDXH) has a current EV/EBIT of -47.76. The 5-year average EV/EBIT is -10.15. The thresholds are as follows: Strongly Undervalued below -29.21, Undervalued between -29.21 and -19.68, Fairly Valued between -0.63 and -19.68, Overvalued between -0.63 and 8.90, and Strongly Overvalued above 8.90. The current Forward EV/EBIT of -47.76 falls within the Strongly Undervalued range.
1.65
PS
MDxHealth SA. (MDXH) has a current PS of 1.65. The 5-year average PS is 1.16. The thresholds are as follows: Strongly Undervalued below -0.83, Undervalued between -0.83 and 0.16, Fairly Valued between 2.15 and 0.16, Overvalued between 2.15 and 3.14, and Strongly Overvalued above 3.14. The current Forward PS of 1.65 falls within the Historic Trend Line -Fairly Valued range.
57.40
P/OCF
MDxHealth SA. (MDXH) has a current P/OCF of 57.40. The 5-year average P/OCF is -3.27. The thresholds are as follows: Strongly Undervalued below -42.29, Undervalued between -42.29 and -22.78, Fairly Valued between 16.23 and -22.78, Overvalued between 16.23 and 35.74, and Strongly Overvalued above 35.74. The current Forward P/OCF of 57.40 falls within the Strongly Overvalued range.
0.00
P/FCF
MDxHealth SA. (MDXH) has a current P/FCF of 0.00. The 5-year average P/FCF is -5.13. The thresholds are as follows: Strongly Undervalued below -12.96, Undervalued between -12.96 and -9.05, Fairly Valued between -1.21 and -9.05, Overvalued between -1.21 and 2.70, and Strongly Overvalued above 2.70. The current Forward P/FCF of 0.00 falls within the Overvalued range.
MDxHealth SA (MDXH) has a current Price-to-Book (P/B) ratio of -262.35. Compared to its 3-year average P/B ratio of -25.71 , the current P/B ratio is approximately 920.34% higher. Relative to its 5-year average P/B ratio of -23.69, the current P/B ratio is about 1007.23% higher. MDxHealth SA (MDXH) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -44534.32%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -113021.47% , the current FCF yield is about -100.00% lower.
-262.35
P/B
Median3y
-25.71
Median5y
-23.69
-6.93
FCF Yield
Median3y
-44534.32
Median5y
-113021.47
Competitors Valuation Multiple
The average P/S ratio for MDXH's competitors is 0.00, providing a benchmark for relative valuation. MDxHealth SA Corp (MDXH) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of MDXH increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of MDXH in the past 1 year is driven by Unknown.
People Also Watch
FAQ
Is MDxHealth SA (MDXH) currently overvalued or undervalued?
MDxHealth SA (MDXH) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -3.68. The fair price of MDxHealth SA (MDXH) is between NaN to NaN according to relative valuation methord.
What is MDxHealth SA (MDXH) fair value?
How does MDXH's valuation metrics compare to the industry average?
What is the current P/B ratio for MDxHealth SA (MDXH) as of Sep 23 2025?
What is the current FCF Yield for MDxHealth SA (MDXH) as of Sep 23 2025?
What is the current Forward P/E ratio for MDxHealth SA (MDXH) as of Sep 23 2025?